Skip to main content

Table 1 Cell cycle in VCaP cells

From: SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo

Cell cycle phase Vehicle DHT SFRP1 SFRP1 + DHT Nocodazole
G1 65.5% ± 3.8 45.1% ± 8.5** 74.2% ± 0.47 62.6% ± 2.8 53.6% ± 1.69
S 25.6% ± 2.6 45.1% ± 11.5* 8.8% ± 0.81 25.4% ± 2.4 18.8% ± 1.35
G2 8.9% ± 1.7 10.7% ± 3.05 17% ± 0.45 12% ± 0.60 27.6% ± 0.23*
  1. Data are the average ± s.d. of a representative experiment carried out in triplicate (*p < 0.005; Student’s t-test of treatments compared to vehicle)